Tom Baker Cancer Centre

New Data by Breast Cancer Canada Reveals 89% of Canadians Believe the Screening Age Should be Lower than 50 Years Old

Retrieved on: 
Thursday, September 28, 2023
Oncology, Data Management, Health, Consumer, Technology, Women, General Health, Desire, Progress, Pros, Radiation, Probability, Tom Baker Cancer Centre, Policy, Cancer, Woman, Human, Research, Multimedia, Patient, Breast cancer, Lymph, Medicine, Artificial intelligence, Diagnosis, AI, BCC, Disease, Birth control, Medical imaging

Today, Breast Cancer Canada (BCC), a national charity dedicated to saving lives through breast cancer research, released new data that highlights Canadian perspectives on breast cancer screening and the need for diverse, lived experiences in research.

Key Points: 
  • Today, Breast Cancer Canada (BCC), a national charity dedicated to saving lives through breast cancer research, released new data that highlights Canadian perspectives on breast cancer screening and the need for diverse, lived experiences in research.
  • (Photo: Breast Cancer Canada)
    The survey, conducted among members of the Angus Reid Forum, found that there is a significant national demand for earlier routine breast cancer screening.
  • Lowering the age for routine breast cancer screening – 89 per cent of Canadians believe routine breast cancer screening should begin before the age of 50.
  • “Canadians are asking for more breast cancer data, and there is a clear need to address the lack of information available.

Parexel Appoints Gwyn Bebb, BM, BCh., Ph.D., to Lead Oncology Clinical Development

Retrieved on: 
Tuesday, September 19, 2023
Amgen, BM, Clinical trials unit, POET, Drug development, University, Tom Baker Cancer Centre, Head, Cancer, Research, Department of Medicine – University of Pamplona, Lung, Natural science, Patient, ChromeOS, Nursing, Medical imaging, Parexel

In this role Dr. Bebb will lead the research and development of new cancer treatments for biopharmaceutical customers worldwide.

Key Points: 
  • In this role Dr. Bebb will lead the research and development of new cancer treatments for biopharmaceutical customers worldwide.
  • “The complexities of oncology require agile, multifaceted teams to push the boundaries of drug development and deliver groundbreaking treatment options for patients with cancer,” said Amy McKee, M.D., Chief Medical Officer and Head, Oncology Center of Excellence.
  • Most recently he was a Clinical Research Medical Director at Amgen in both early- and late-stage oncology drug development where he shepherded a biphasic T cell engager to a confirmational Phase III trial.
  • His experience also includes clinical practice as a Medical Oncologist focused on lung and gastrointestinal cancers.

New Data Analysis Shows Increase in Cancer Caregivers in Canada, and the Significant Impact of COVID-19

Retrieved on: 
Tuesday, April 19, 2022
Well, Society, ASCO, Awareness, Neurology, Muscular dystrophy, Multiple sclerosis, Part, COVID-19, Parkinson's disease, Caregiver, Merck Group, Dementia, Fertility, Patient, Merck Millipore, American Society of Clinical Oncology, Merck Serono, Merck, Tom Baker Cancer Centre, Technology, Disease, Endocrinology, Index, Cancer, Residential care, Pharmaceutical industry

The new analysis of The Carer Well-Being Index shows Canadian cancer caregivers' responses compared to Canadian caregivers in other groups (e.g., muscular dystrophy, multiple sclerosis, dementia, Parkinson's disease).

Key Points: 
  • The new analysis of The Carer Well-Being Index shows Canadian cancer caregivers' responses compared to Canadian caregivers in other groups (e.g., muscular dystrophy, multiple sclerosis, dementia, Parkinson's disease).
  • During the pandemic the increasing pressures of caring for a sick loved one, particularly one with cancer, have received much less attention.
  • 28 per cent of respondents became first time caregivers to cancer patients in the previous year compared to 12 per cent to those in other non-cancer caregiving groups.
  • "At EMD Serono, we understand the crucial role caregivers play in Canadians' lives," said Manuel Zafra, Managing Director, EMD Serono Canada.

Alberta Cancer Foundation Announces Cash and Cars Lottery Prizes

Retrieved on: 
Thursday, July 22, 2021
Provinces and territories of Canada, Lottery, Tom Baker Cancer Centre, Alberta, Calgary

CALGARY, AB, July 22, 2021 /CNW/ - Today,the Alberta Cancer Foundation announces this year's Cash and Cars Lottery prizes, which includes over 2,000 prizes valued at over $3.7 million.

Key Points: 
  • CALGARY, AB, July 22, 2021 /CNW/ - Today,the Alberta Cancer Foundation announces this year's Cash and Cars Lottery prizes, which includes over 2,000 prizes valued at over $3.7 million.
  • "The Cash & Cars Lottery is one of the most supported lotteries in Alberta which means for every Cash and Cars Lottery ticket purchased, an Albertan facing cancer is helped," said Wendy Beauchesne, CEO, Alberta Cancer Foundation.
  • The Alberta Cancer Foundation is the official fundraising partner for the 17 Alberta Health Services cancer centres across the province, including the Cross Cancer Institute and the Tom Baker Cancer Centre.
  • To learn more about the Alberta Cancer Foundation, please visit www.albertacancer.ca
    To learn more about the Cash and Cars Lottery, please visit cashandcarslottery.ca